Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-266-7 | CAS number: 774-55-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Toxicity: Oral:
According to the study, the acute oral median lethal dasage (LD50) calculated by probit analysis, were:
Rats:
- male: 2600 mg/kg
- female: 2700 mg/kg
- combined sexes: 2650 mg/kg
Mice:
- male: 3000 mg/kg
- female: 2900 mg/kg
- combined sexes: 2950 mg/kg
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2 September - 9 October 1985
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Initial Screening was carried out in six groups, each of two males and two females rats and mice in order to find the general level of acute toxicity of the test material. After these preliminary observation, test material was administered by gavage of rats in single dose of 1680, 2100, 2630, 3260, 4110 mg per kg body weight and the stomach of mice in single dose of 1400, 1700, 2100, 2600, 3300, 4100, 5200 mg per kg body weight. For each dose five males and five females were used. After treatment, the rats and mice were odserved for signs of intoxication during the first 4 post-treatment hours and thereafter daily throughout a 14 day observation period. Individual body weights were determined on day 0, 7 and 14. At the end of the observation period the survivors were killed and ewamined grossly. The LD50 was calculated according to the method of Litchfield-Wilcoxon.
- GLP compliance:
- not specified
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- and mice
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: rats: approximately 35 days old, mice: 49 days old
- Weight at study initiation: 120g to 140g for male rats, 110g to 130g for female rats. 12g to 31g for the mice
- Fasting period before study: on the day of dosing test material
- Housing: polycarbonate cages with stainless steel grid tops
- Diet: complete pelleted rodent diet was fed without restriction
- Water: tap water freely available
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 25°C ± 2°C
- Humidity (%): 45 - 75 %
- Air changes: yes
- Photoperiod (hrs dark / hrs light): artificial light with a sequence of 12 hours light and 12 hours dark - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Single dose of the test material
Doses during the preliminary study:
Rats: 500, 1000, 2000, 4000 and 6000 mg/kg
Mice: 200, 500, 1000, 2000, 4000 and 8000 mg/kg - Doses:
- Rats: 1680, 2100, 2630, 3260 and 4110 mg/kg bw
Mice: 1400, 1700, 2100, 2600, 3300, 4100 and 5200 mg/kg bw - No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: first 4 post-treatment hours then daily throughout a 14 day observation period
- Necropsy of survivors performed: yes - Preliminary study:
- Rats: mortalitily at dose levels of 4000 mg/kg and 6000 mg/kg observed
Mice: mortalitily at dose levels of 4000 mg/kg and 8000 mg/kg observed - Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Remarks:
- Rats
- Effect level:
- 2 600 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Remarks:
- Rats
- Effect level:
- 2 700 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Rats
- Effect level:
- 2 650 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Remarks:
- Mice
- Effect level:
- 3 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Remarks:
- Mice
- Effect level:
- 2 900 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Mice
- Effect level:
- 2 950 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Deaths occured between 6 hours and 2 days after treatment. Then the survivors recovered gradually and looked quite healthy again at the end of the observation period.
- Gross pathology:
- Macroscopic examination of the survivors at autopsy did not reveal any treatment-related gross alteration.
- Other findings:
- See attachment for results.
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Under the conditions of this study the acute oral median lethal dasage (LD50) calculated by probit analysis, were:
Rats:
- male: 2600 mg/kg
- female: 2700 mg/kg
- combined sexes: 2650 mg/kg
Mice:
- male: 3000 mg/kg
- female: 2900 mg/kg
- combined sexes: 2950 mg/kg
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 650 mg/kg bw
Additional information
Justification for classification or non-classification
According to the Annex I: 3.1.2.1, Table 3.1.1 of the CLP regulation, the test substance is not classified.
According to the Chapter 3.1, Table 3.1.1 of the GHS classification, the test item is classified ATO 5.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.